Key 2026 Market Insights: Coordination, Clarity & Growth Signals

Why the macro market is shifting toward integrated care and what it means for investors and providers. 1. V28 & the New Economics of Care: Why Coordinated Support for Complex Patients Is the Next Growth Market CMS V28 Final Rulehttps://www.aapc.com/blog/93459-cms-hcc-model-v28 Strengthens incentives for longitudinal, coordinated care—directly aligning with Ursamin’s core value proposition. In 2026, healthcare […]

Navigating the New Medicare Advantage with a Shift to Outcomes

medical advantage blog

Medicare Advantage is undergoing a fundamental shift as the industry works to move towards improved quality care. With new regulations like V28, the government is reducing payments for common chronic conditions such as diabetes and heart failure. The initial shift in reimbursement was designed to sharpen focus on high-risk patients by incentivizing providers to deliver better […]

Ursamin – Leading the Surge in Healthcare Innovation

ursamin investment

Ursamin is leading the surge in healthcare innovation, capturing 42% of the investment spotlight in a shifting market. As a late-stage pre-seed opportunity, we offer investors a fast track to a quick exit in a booming sector. Join us to transform healthcare—read more now.